galtomone
21.03.20, 10:23
time.com/5806312/coronavirus-treatment-cost/
Warto zwrócić uwagę, na kilka spraw.
Maja na razie ustawe, ktora zdejmuje z ludzi koszty samych testow. Ale dla tych, ktorzy beda musieli isc do szpitala sytuacja sie komplikuje...
Sa albo nielegalni... wiec szanse na to, ze godziekolwiek sie zglosza sa minimalne... A to znaczy dalsze roznoszenie wirusa... w fabrykach, u bogatszych ludzi dla ktorych pracuja, albo brak pracy (bo przez strach zostana zwolnieni) i w praktyce zdychanie na ulicy.
Ale sa tez bardzo rozne poziomy ubepzieczenia, tego ile, za co sie placi, itd... System generalnie ma najpierw przynosic zyski, a potem leczyc, jesli sie uda... (stad ci co maja wysokie ubezpieczenia sa ofiarami tzw. nadgorliwosci - tzn. zleca sie duzo dodatkowych testow, by szpital mogl obciążyć ubezpieczalnie).
"A new analysis from the Kaiser Family Foundation estimates that the average cost of COVID-19 treatment for someone with employer insurance—and without complications—would be about $9,763. Someone whose treatment has complications may see bills about double that: $20,292. (The researchers came up with those numbers by examining average costs of hospital admissions for people with pneumonia.)
[...]
Most private health insurance plans are likely to cover most services needed to treat coronavirus complications, but that doesn’t include your deductible—the cost you pay out-of-pocket before your insurance kicks in. More than 80% of people with employer health insurance have deductibles, and last year, the average annual deductible for a single person in that category was $1,655. For individual plans, the costs are often higher. The average deductible for an individual bronze plan in 2019 was $5,861, according to Health Pocket.
In both complicated and uncomplicated cases, patients with employer-based insurance can expect out-of-pocket costs of more than $1,300, the Kaiser researchers found. "
Drogo w tych USA....
www.investopedia.com/articles/personal-finance/072116/us-healthcare-costs-compared-other-countries.asp
Bimota, i konkuluzja dla Ciebie
"“There is no reason why identical procedures and products should vary in price so much across countries: it illustrates the damaging effects of an inadequately regulated healthcare market," - Sackville said."
